Henan Cancer Hospital

This study tested whether adding lenalidomide to standard chemotherapy (R-CHOP) could improve outcomes for people with a fast-growing type of lymphoma called diffuse large B-cell lymphoma. The trial included 60 patients with medium-to-high risk disease who had not yet received tr…

This study tested a combination of two drugs (durvalumab and anlotinib) plus standard chemotherapy as a first treatment for people with extensive-stage small-cell lung cancer, a fast-growing cancer. 34 adults took part. The goal was to see if the combo could slow cancer growth be…

This study tested a combination of drugs called VR-CAP as a first treatment for people with marginal zone lymphoma, a rare blood cancer. 26 patients received the therapy to see how well it controlled the disease over two years. The goal was to measure how long patients lived with…

This study tested a pill called hetrombopag in 60 people with advanced breast cancer who had low platelets from chemotherapy. The goal was to see if the drug could safely raise platelet levels and reduce the need for platelet transfusions or chemo delays. Results will help guide …

This study tested a combination of two drugs (toripalimab and gemcitabine) given before surgery to people with muscle-invasive bladder cancer who cannot take the standard chemotherapy drug cisplatin. The goal was to see how well the drugs shrink tumors before the bladder is remov…